Navigation Links
Fate Therapeutics Created by Leading Stem Cell Scientists to Pursue New Approaches to Stem Cell Therapies

iology and Regenerative Medicine and HHMI has pioneered the use of

synthetic small molecules and natural products to manipulate activities

of developmental and stem cell signaling pathways in vitro and in vivo.

-- Sheng Ding, Ph.D., Scripps Research Institute, has worked on the

identification of small molecules and genes that control cell fate,

including cell reprogramming and differentiation. Dr. Ding's work has

important implications for the development of small molecule drugs that

can potentiate adult stem cells in vivo, and reprogram differentiated

cells to new functions.

-- Randall Moon, Ph.D., University of Washington, Director, Institute for

Stem Cell and Regenerative Medicine, HHMI, and UW Department of

Pharmacology, has focused on illuminating the biological pathways that

control adult stem cells during the process of regeneration to develop

new therapeutic methods to activate regeneration.

-- David Scadden, M.D., Professor, Harvard University, Co-director and

Co-founder, Harvard Stem Cell Institute, Director Massachusetts

General Hospital Center for Regenerative Medicine, has broken new

ground in understanding how blood forming stem cells and other adult

stem cells are maintained in the adult body in specialized niches, and

in developing therapies that exploit this biology to modulate adult

stem cells in vivo.

-- Leonard Zon, M.D., Harvard University, Director of the Stem Cell

Program, Children's Hospital of Boston, and HHMI, is a world expert on

the biology of adult blood forming stem cells and methods of enhancing

their function for cancer and regenerative medicine applications

Esteemed scientists to join Fate's Science Advisory Board

In addition to the founding scientists, Fate Therapeutics has garnered the expertise of additional stem ce

SOURCE Fate Therapeutics
Copyright©2007 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related biology technology :

1. Vicus Therapeutics to Present at the 234th American Chemical Society National Meeting in Boston, MA
2. DJO Incorporateds Pending Merger With ReAble Therapeutics Clears U.S. Antitrust Review
3. PeriCor Therapeutics Announces Closing of Licensing Agreement for Acadesine with Schering-Plough Corporation
4. Systems Medicine (SM), a Subsidiary of Cell Therapeutics, Inc. (CTI), Announces Execution of CRADA with NCI/NIH to Develop Potential Cancer Treatments Targeting the Insulin Growth Factor (IGF) Pathway
5. Amsterdam Molecular Therapeutics to Release H1 2007 Results on August 29, 2007
6. Nektar Therapeutics Appoints Tim Harkness as Chief Financial Officer
7. ExonHit Therapeutics: Allergan and ExonHits First Collaboration Compound to Begin Human Clinical Trials
8. Cell Therapeutics, Inc. Takes Corrective Actions in Response to Nasdaq Determination
9. Amsterdam Molecular Therapeutics Reports Half Year Results 2007
10. Nektar Therapeutics Appoints Lutz Lingnau as New Board Member
11. Anesiva Grants Specific-Use License of Its Needle-Free Drug Delivery Technology to Particle Therapeutics for Diabetes Drug
Post Your Comments:
(Date:10/8/2015)...  Today the Wyss Institute for Biologically Inspired Engineering ... company Opsonix Inc. The announcement follows a ... Technology Development (OTD) and Opsonix Inc. enabling the ... use. --> --> ... every year in the U.S. — more than prostate ...
(Date:10/7/2015)... , October 8, 2015 ... Medical biotechnology accounts for largest bioinformatics market ... in drug discovery and development process says ... . --> ... the basis of applications, the bioinformatics market ...
(Date:10/7/2015)... , Oct. 7, 2015  ContraVir Pharmaceuticals, Inc. (Nasdaq: ... company focused on the development and commercialization of targeted ... public offering of 5,000,000 shares of its common stock ... the Company,s common stock at a fixed combined price ... stock and warrants will be issued separately.  The warrants ...
(Date:10/7/2015)... (PRWEB) , ... October 07, 2015 , ... ... today announced a webinar titled Smart Nanostructured Coatings to provide a comprehensive overview ... Register for this free webinar at . This webinar will be ...
Breaking Biology Technology:
... May 25, 2010 t2cure GmbH, a biopharmaceutical,company developing and ... product t2c001 has been,certified by the European Medicines Agency (EMA). , ... t2c001 is ... Advanced Therapy Medicinal Products (ATMPs). It is a somatic,cell therapy product derived ...
... ... In the India, CJP is all set to hold 5 Days ... The JatrophaWorld Training Programme 2010-- the Most Authoritative platform shall introduce ... and application technologies, including utilization of Jatropha Crude Oil and Seedcake; ...
... ... ... never before use sustainable farming methods to meet a growing global food demand, and a new ... look at how they do it. , , ,The new website, which can be found ...
Cached Biology Technology:
(Date:9/2/2015)... Biometric technology ... system which uses identical human characteristic such as ... and finger print. Increasing number of terror attacks ... which provides high level of security. Traditional security ... are vulnerable to attacks. Furthermore, Biometric technology uses ...
(Date:8/31/2015)... , August 31, 2015 Growing ... technology in government digitization projects to drive India ... recently published TechSci Research report, " India Biometrics Market Forecast ... is projected to grow at a CAGR of ... is anticipated on account of extensive use of biometric technology ...
(Date:8/28/2015)... August 28, 2015 According to ... Market by Assessment Type (Pen & Paper Based, Hosted, ... Corporate Learning, Academic Research), Vertical and Region - Global ... Training Market to grow from USD 2.4 Billion in ... Compound Annual Growth Rate (CAGR) of 25.6% from 2015 ...
Breaking Biology News(10 mins):
... Wake Forest University School of Medicine suggests that certain inhaled ... during times of high stress ?may worsen diseases such as ... scientific team led by Raymond Penn, Ph.D., and Matthew Loza, ... treatment of asthma, increase the accumulation of type 2 T ...
... Hopkins have shown that transplanting human stem cells into ... disease delays the start of nerve cell damage typical ... stem cells develop into nerve cells that make substantial ... to Lou Gehrig's, also known as amyotrophic lateral sclerosis ...
... with researchers at Rutgers University have solved longstanding ... carrying out instructions contained in our genes. The ... 17 issue of the journal Science reveals important ... transcription and the effects of those gyrations on ...
Cached Biology News:
Request Info...
jub, ajuba homolog (Xenopus laevis)...
AGAROSE PREP, 50G, 1 EA. Category: Genephor Precast Gels....
... Markers, 37 kBq, 1 uCi. Carbon-14 radiolabelled ... the sample on Western blots.The Rainbow-labeled version ... in the gel and on the blot.The ... Rainbow-labeling is 0.37-3.7 MBq/mg (10-100 uCi/mg) or ...
Biology Products: